David Shapiro - Chief Medical Officer, Intercept Pharmaceuticals, Inc
As of May 3, 2019
David Shapiro Net Worth
- Net worth is estimated to be at least $37.73M
- Owns at least 39,499 units of Intercept Pharmaceuticals, Inc stock
- Sold an estimated value of $37.52M in the last 7 years at Intercept Pharmaceuticals, Inc
David Shapiro Trading
- Largest purchase of shares was 8,917 units , worth over $92.74K on March 19, 2014
- Largest sale of shares was 10,000 units , worth over $2.94M on August 29, 2014
- In total has made about 78 transactions over 7 years
- Usually trades in January, with the busiest year in 2015
David Shapiro
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
David Shapiro Mailing Address
- Mailing address is C/o Intercept Pharmaceuticals, Inc. 18 Desbrosses St. New York NY 10013 NY
Intercept Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mark Pruzanski, M.D., | 2020 | $757,850 | - | $4,113,504 | $1,015,996 | $531,995 | $7,660 | $6,427,005 |
| Mark Pruzanski, M.D., | 2019 | $734,292 | - | $4,197,742 | $1,116,118 | $560,265 | $7,368 | $6,615,785 |
| Mark Pruzanski, M.D., | 2018 | $702,000 | - | $1,667,718 | $1,705,358 | $442,260 | $8,623 | $4,525,960 |
| Jerome Durso, | 2020 | $599,524 | - | $2,057,016 | $998,776 | $231,737 | $21,910 | $3,908,963 |
| Jerome Durso, | 2019 | $573,250 | - | $2,089,570 | $1,238,321 | $359,284 | $21,368 | $4,281,793 |
| Jerome Durso, | 2018 | $540,800 | - | $1,554,326 | $775,844 | $292,032 | $22,403 | $3,185,406 |
| Sandip Kapadia, | 2020 | $476,863 | - | $1,087,836 | $528,088 | $184,039 | $21,910 | $2,298,736 |
| Sandip Kapadia, | 2019 | $464,100 | - | $1,001,664 | $586,573 | $252,935 | $21,368 | $2,326,640 |
| Sandip Kapadia, | 2018 | $442,000 | - | $790,164 | $393,544 | $228,735 | $22,403 | $1,876,846 |
| Richard Kim, | 2020 | $456,095 | - | $1,044,360 | $505,128 | $168,056 | $79,211 | $2,252,850 |
| Richard Kim, | 2019 | $442,900 | $202,800 | $890,368 | $521,398 | $265,519 | $76,343 | $2,399,328 |
| Lisa Bright, | 2020 | $480,552 | - | $925,704 | $453,467 | $240,955 | $139,106 | $2,239,784 |
| Ryan Sullivan, | 2020 | $437,107 | - | $1,087,836 | $528,088 | - | $89,942 | $2,142,973 |
| Ryan Sullivan, | 2019 | $445,520 | - | $1,471,902 | $871,713 | $267,089 | $21,368 | $3,077,592 |
| Ryan Sullivan, | 2018 | $376,158 | - | $1,239,112 | $1,190,351 | $229,122 | $173,437 | $3,208,180 |
| Christian Weyer, M.D., M.A.S., | 2020 | $486,731 | - | $925,704 | $453,467 | $170,804 | $21,910 | $2,058,616 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1270073/000110465921055639/tm218121-2_def14a.htm
Intercept Pharmaceuticals, Inc Insider Trading
- The most recent transaction was 237,000 units bought on March 12, 2021 by Srinivas Akkaraju worth over $5.02M
- In the last 9 years, insiders at Intercept Pharmaceuticals, Inc sold an estimated value of $1.66B and bought an estimated value of $148.73M
- The most active traders are David Shapiro, Chief Medical Officer, Mark Pruzanski, Director, and Lisa Bright, President
- Insider trading is most common in January, with the busiest year in 2019
INTERCEPT PHARMACEUTICALS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||